How should oral hydrocortisone be used to treat allergic hives in an otherwise healthy adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Hydrocortisone for Allergic Hives

Oral hydrocortisone should be reserved for short courses (3-4 days) in severe acute urticaria that is unresponsive to antihistamines alone, starting at 40-50 mg daily (equivalent to prednisone 10-12.5 mg), but should NOT be used routinely as first-line therapy. 1

Treatment Algorithm

First-Line Treatment

  • Start with H1 antihistamines as monotherapy - this is the undisputed mainstay of urticaria treatment 1
  • Use second-generation, non-sedating antihistamines (cetirizine, loratadine, fexofenadine, desloratadine, levocetirizine) taken regularly, not as-needed 2
  • If inadequate response, updose the antihistamine (2-4x the standard dose) before adding corticosteroids 3

When to Consider Oral Corticosteroids

Add a short course of oral corticosteroids only if:

  • Severe acute urticaria with significant symptoms despite antihistamines
  • Pruritus score >5/10 on visual analog scale
  • Severe angioedema affecting the mouth 1

Dosing Specifics

  • Hydrocortisone: 100-250 mg daily for 3-4 days 4, 5
    • Alternatively, use prednisone 20-40 mg daily (more commonly prescribed) 6, 5
    • 20 mg hydrocortisone = 5 mg prednisone equivalency 4
  • Taper rapidly over 3-4 days and discontinue 1, 5
  • Do NOT prescribe prolonged courses - this increases adverse events without additional benefit 7, 8

Evidence Quality and Nuances

The evidence for corticosteroids in urticaria is mixed:

  • A 2024 meta-analysis found that corticosteroids likely improve urticaria activity by 14-15% absolute difference in patients with low-to-moderate antihistamine responsiveness (NNT=7), but only 2.2% improvement in high responders (NNT=45) 7
  • Critical caveat: The same study found corticosteroids likely increase adverse events by 15% (NNH=9) 7
  • A 2021 randomized trial found no benefit from adding IV dexamethasone to antihistamines for acute urticaria, and oral corticosteroids were associated with persistent urticaria activity 8
  • However, a 1995 trial showed prednisone burst improved itch scores significantly at 2 and 5 days (P<0.0001) 5

The strongest guideline evidence (2007 British guidelines) explicitly states: "Oral corticosteroids should be restricted to short courses for severe acute urticaria or angioedema affecting the mouth" 1

Common Pitfalls to Avoid

  1. Do not use corticosteroids as first-line therapy - antihistamines must be tried first and optimized 3, 1
  2. Do not prescribe extended courses - no evidence supports use beyond 4-5 days for acute urticaria 1, 7
  3. Do not use for chronic urticaria maintenance - only 47% achieve remission with a short course, and most relapse 6
  4. Rare paradoxical reactions: Hydrocortisone itself can cause allergic skin reactions in presensitized individuals 9
  5. Monitor for adverse effects: Even short courses increase side effects by 15% 7

Special Populations

  • Pregnancy: Avoid all corticosteroids when possible, especially first trimester 1
  • Renal/hepatic impairment: Adjust antihistamine doses first; corticosteroids require standard monitoring 1

Bottom Line

Hydrocortisone/corticosteroids are adjunctive therapy only for severe, antihistamine-resistant acute urticaria. The 2022 international guidelines have streamlined urticaria management to a 3-step algorithm: (1) antihistamines with updosing, (2) omalizumab for chronic cases, (3) cyclosporine for refractory disease 3. Short-course corticosteroids fit only as a bridge therapy in acute severe presentations, not as routine management.

References

Research

Evidence-based use of antihistamines for treatment of allergic conditions.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2023

Guideline

chronic spontaneous urticaria guidelines: what is new?

Journal of Allergy and Clinical Immunology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.